Pace Jesse A, Bronstein Robert, Guo Yiqing, Yang Yaqi, Estrada Chelsea C, Gujarati Nehaben, Salant David J, Haley John, Bialkowska Agnieszka B, Yang Vincent W, He John C, Mallipattu Sandeep K
Division of Nephrology and Hypertension, Department of Medicine, Stony Brook University, Stony Brook, NY, USA.
Division of Nephrology, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Sci Adv. 2021 Sep 3;7(36):eabg6600. doi: 10.1126/sciadv.abg6600.
Podocyte loss triggering aberrant activation and proliferation of parietal epithelial cells (PECs) is a central pathogenic event in proliferative glomerulopathies. Podocyte-specific Krüppel-like factor 4 (KLF4), a zinc-finger transcription factor, is essential for maintaining podocyte homeostasis and PEC quiescence. Using mice with podocyte-specific knockdown of Klf4, we conducted glomerular RNA-sequencing, tandem mass spectrometry, and single-nucleus RNA-sequencing to identify cell-specific transcriptional changes that trigger PEC activation due to podocyte loss. Integration with in silico chromatin immunoprecipitation identified key ligand-receptor interactions, such as fibronectin 1 (FN1)–αVβ6, between podocytes and PECs dependent on KLF4 and downstream signal transducer and activator of transcription 3 (STAT3) signaling. Knockdown of Itgb6 in PECs attenuated PEC activation. Additionally, podocyte-specific induction of human KLF4 or pharmacological inhibition of downstream STAT3 activation reduced FN1 and integrin β 6 (ITGB6) expression and mitigated podocyte loss and PEC activation in mice. Targeting podocyte-PEC crosstalk might be a critical therapeutic strategy in proliferative glomerulopathies.
足细胞丢失引发壁层上皮细胞(PEC)异常激活和增殖是增殖性肾小球病的核心致病事件。足细胞特异性Krüppel样因子4(KLF4)是一种锌指转录因子,对维持足细胞稳态和PEC静止至关重要。我们使用足细胞特异性敲低Klf4的小鼠,进行了肾小球RNA测序、串联质谱分析和单核RNA测序,以确定因足细胞丢失而触发PEC激活的细胞特异性转录变化。与计算机模拟染色质免疫沉淀相结合,确定了足细胞与PEC之间关键的配体-受体相互作用,如纤连蛋白1(FN1)-αVβ6,其依赖于KLF4和下游信号转导子及转录激活子3(STAT3)信号传导。在PEC中敲低Itgb6可减弱PEC激活。此外,足细胞特异性诱导人KLF4或对下游STAT3激活进行药理学抑制,可降低FN1和整合素β6(ITGB6)表达,并减轻小鼠足细胞丢失和PEC激活。靶向足细胞-PEC相互作用可能是增殖性肾小球病的关键治疗策略。